Updates
Mr. Kapil Mehan (DIN: 01215092), Non-Executive Director has resigned from the Board of Directors of the Company with effect from June 03, 2017. This disclosure is made pursuant to Regulation 30(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). The present composition of the Board of Directors, which is in compliance with Regulation 17 of the Listing Regulations, is as follows:... Updates
We had submitted the Audited Standalone Financial Results for the quarter and the year ended March 31, 2017 vide our letter dated May 18, 2017 along with Auditor's Report thereon. We attach herewith the Audited Standalone Financial Results for the quarter and the year ended March 31, 2017 as per the formats for the Balance Sheet and Statement of Profit and Loss (excluding notes and detailed sub-classification) as prescribed in Schedule III to the Companies Act, 2013. Credit Rating
Pursuant to the provisions of Regulation 30 and Sub Para 3 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby write to inform you that based on our request, CRISIL has, vide its letter dated May 24, 2017, withdrawn the ratings assigned to bank facilities of the Company. Updates
We had submitted the Audited Standalone Financial Results for the quarter and the year ended March 31, 2017 vide our letter dated May 18, 2017 along with Auditor's Report thereon. We attach herewith the corrected copy of the Auditor's Report on Quarterly financial results and year to date results for the year ended March 31, 2017. Kindly take the same on record. Credit Rating
Pursuant to the provisions of Regulation 30 and Sub Para 3 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that, CARE has revised the Long Term Rating to CARE BBB; Stable (read as Triple B; Outlook: Stable) from CARE BBB-;Stable and Short Term Rating to CARE BBB; Stable / CARE A3 (read as Triple B; Outlook: Stable / A Three) from CARE BBB-;Stable / CARE A3. The rationale... Board recommends Dividend
Mangalore Chemicals & Fertilizers Ltd has informed BSE that the Board of Directors of the Company in its meeting held May 18, 2017, inter alia, has considered and approved the following:- Recommended a dividend of Re. 0.50 per equity share of Rs. 10 each for the financial year ended March 31, 2017 which is subject to approval of the members at the ensuing Annual General Meeting. Updates
In terms of amendment to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 vide notification dated May 25, 2016 read with SEBI s circular No.CIR/CFD/CMD/56/2016 dated May 27, 2016, we hereby declare that the Statutory Auditors of the Company have issued an unmodified audit report on the financial results of the Company for the year ended March 31, 2017 Financial Results For The Quarter And The Year Ended March 31, 2017
The Board of Directors of the Company in its meeting held today, May 18, 2017, inter alia, has considered the approved the following: 1 Audited financial results of the Company for the quarter and the year ended March 31, 2017 as recommended by the Audit Committee at its meeting held today May 18, 2017 2. Recommended a dividend of Re.0.50 per equity share of Rs.10 each for the financial year ended March 31, 2017 which is subject to approval of... Board to consider Dividend
Mangalore Chemicals & Fertilizers Ltd has informed BSE that a meeting of the Board of Directors is scheduled on May 18, 2017, inter alia, to consider:1. Audited financial results for the quarter and the year ended March 31, 2017.2. Recommendation of dividend, if any, for the year 2016-2017.In terms of the Company's Code of Conduct to regulate, monitor and report trading by an Insider, the Trading Window is closed from May 06, 2017 to May 20, 2017 (both days inclusive).